Potential Benefits From Heating the High-Dose rtPA Boluses Used in Catheter-Directed Thrombolysis for Acute/Subacute Lower Limb Ischemia

Journal of Endovascular Therapy

Volumn 10, Issue 4, 2003, Pages 739-744

  Tsetis, Dimitrios K ^a   Katsamouris, Asterios N ^a   Giannoukas, Athanasios D ^a   Hatzidakis, Adam A ^a   Kostas, Theodoros ^a   Chamalakis, Konstantinos ^a   Ioannou, Christos ^a   Gourtsoyiannis, Nicholas C ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Hyperthermic fibrinolysis; Lower limb ischemia; Recanalization; Recombinant tissue plasminogen activator; Thrombolysis; Thrombosis

Indexed keywords

ALTEPLASE; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ADULT; AGED; ARTERY OCCLUSION; ARTICLE; BLOOD CLOT LYSIS; CATHETERIZATION; CHI SQUARE DISTRIBUTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTINUOUS INFUSION; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; FIBRINOLYTIC THERAPY; HEAT; HEATING; HUMAN; HYPERTHERMIC THERAPY; ISCHEMIA; LEG; LEG ISCHEMIA; MALE; METHODOLOGY; NONPARAMETRIC TEST; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROPERITONEAL HEMATOMA; ROOM TEMPERATURE; STATISTICAL SIGNIFICANCE; STENT; TREATMENT OUTCOME; VASCULARIZATION;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; CHI-SQUARE DISTRIBUTION; FEMALE; HEAT; HUMANS; ISCHEMIA; LEG; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECOMBINANT PROTEINS; STATISTICS, NONPARAMETRIC; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0242300256     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/1545-1550(2003)010<0739:PBFHTH>2.0.CO;2     Document Type: Article

References (24)

1. Nilsson L, Albrechtsson U, Jonung T, et al. Surgical treatment versus thrombolysis in acute arterial occlusion: a randomized controlled study. Eur J Vasc Surg. 1992;6:189-193.
2. Ouriel K, Shortell CK, DeWeese JA, et al. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg. 1994;19:1021-1030.
3. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE Trial. Ann Surg. 1994;220:251-268.
4. Graor RA, Risius B, Denny KM, et al. Local thrombolysis in the treatment of thrombosed arteries, bypass grafts, and arteriovenous fistulas. J Vasc Surg. 1985;2:406-414.
5. McNamara TO, Bomberger RA. Factors affecting initial and 6 month patency rates after intraarterial thrombolysis with high-dose urokinase. Am J Surg. 1986;152:709-712.
6. Endoarterial treatment of acute ischemia of the limbs with urokinase. Italian Cooperative Study (Bologna). Int Angiol. 1989;8:53-56.
7. Sicard GA, Schier JJ, Totty WG, et al. Thrombolytic therapy for acute arterial occlusion. J Vasc Surg. 1985;2:65-78.
8. Lonsdale RJ, Berridge DC, Earnshaw JJ, et al. Recombinant tissue-type plasminogen activator is superior to streptokinase for local intra-arterial thrombolysis. Br J Surg. 1992;79:272-275.
9. Meyerovitz MF, Coldhaber SZ, Reagan K, et al. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial. Radiology. 1990;175:75-78.
10. Weaver FA, Comerota AJ, Youngblood M, et al. Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity. J Vasc Surg. 1996;24:513-523.
11. Ouriel K, Gray B, Clair DG, et al. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis. J Vasc Interv Radiol. 2000;11:295-298.
12. Swischuk JL, Fox PF, Young K, et al. Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: results and complications. J Vasc Interv Radiol. 2001;12:423-430.
13. Yenari MA, Palmer JT, Bracci PM, et al. Thrombolysis with tissue plasminogen activator (tPA) is temperature dependent. Thromb Res. 1995;77:475-481.
14. Schwarzenberg H, Muller-Hulsbeck S, Brossman J, et al. Hyperthermic fibrinolysis with rtPA: in vitro results. Cardiovasc Intervent Radiol. 1998;21:142-145.
15. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517-538.
16. Berridge DC, Gregson RH, Hopkinson BR, et al. Randomized trial of intra-arterial recombinant tissue plasminogen activator, intravenous recombinant tissue plasminogen activator and intra-arterial streptokinase in peripheral arterial thrombolysis. Br J Surg. 1991;78:988-995.
17. Mahler F, Schneider E, Hess H, the Steering Committee, Study on Local Thrombolysis. Recombinant tissue plasminogen activator versus urokinase for local thrombolysis of femoropopliteal occlusions: a prospective, randomized multicenter trial. J Endovasc Ther. 2001;8:638-647.
18. Braithwaite BD, Buckenham TM, Galland RB, et al. Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Br J Surg. 1997;84:646-650.
19. Belli AM. Thrombolysis in the peripheral vascular system. Cardiovasc Intervent Radiol. 1998;21:95-101.
20. Braithwaite BD, Birch PA, Poskitt KR, et al. Accelerated thrombolysis with high dose bolus t-PA extends the role of peripheral thrombolysis but may increase the risks. Clin Radiol, 1995;50:747-750.
21. Rao AK, Pratt C, Berke A, et al. Thrombolysis in myocardial infarction (TIMI) trial-phasel: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol. 1988;11:1-11.
22. Weitz JI. Limited fibrin specificity of tissue-type plasminogen activator and its potential link to bleeding. J Vasc Interv Radiol. 1995;6:19S-23S.
23. Verstraete M, Bounameaux H, De Cock F, et al. Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans. J Pharmacol Exp Ther. 1985;235:506-512.
24. Aschoff J, Wever R. Kern und Schale im Heatehaushalt des Menschen. Naturwissenschaften. 1958;45:477-481.